Kimberly Clark Corp (KMB) · Oct 13, 2026 · Acquisition
Consent secured — Requisite consents received for all outstanding Kenvue note series
Kimberly-Clark’s acquisition financing advances as Kenvue bondholders approve indenture changes, but the filing largely confirms an expected closing step.
Kimberly-Clark is moving from announcing the Kenvue deal to executing its financing and closing mechanics. The company has positioned the acquisition as the next step in its transformation into a broader health-and-wellness business, with the transaction expected to close in the fourth quarter of 2026.
The key hurdle cleared: Kenvue bondholders approved the proposed indenture changes across every outstanding note series. Kenvue has executed a supplemental indenture, but the amendments do not become operative until the exchange offers settle. 〔0〕 (Consent Solicitation)
This advances the acquisition’s financing process, but it is not a new strategic development. Kimberly-Clark is offering up to $7.0 billion of new notes plus cash in exchange for Kenvue debt, while the exchange remains conditional on the acquisition closing. Early participants receive $970 of Kimberly-Clark notes, $30 of additional notes and $1 in cash for each $1,000 of Kenvue notes; later tenders retain the $30 premium but lose the cash payment. (Exchange Offers)
The filing reduces execution uncertainty, not transaction uncertainty. The exchange expiration is set for October 27, 2026 unless extended, and settlement is not expected before November 2, 2026; both remain tied to completion of the acquisition. 〔1〕 (Settlement Timing)
Bottom line: Kimberly-Clark cleared a required financing step for the Kenvue acquisition, but the filing mostly confirms an expected part of the closing process rather than changing the deal’s underlying story.
Kenvue acquisition closing and exchange settlement, expected after November 2
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!